Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell death encompasses multiple molecularly distinct but often interconnected processes whose manipulation remains at the heart of modern oncology research and drug development efforts. The main forms of regulated cell death (RCD) relevant to tumors include apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagic cell death. Induction or modulation of these pathways is a major strategy in anticancer therapy. Cellular debris from dying tumor cells can modulate immune responses.
Various mechanisms depending on the specific cell death pathway targeted (e.g., caspase activation for apoptosis, RIPK1/RIPK3 activation for necroptosis, induction of lipid peroxidation for ferroptosis).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Death.